Business Description
Eckert & Ziegler SE
ISIN : DE0005659700
Description
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | 0.94 | |||||
| Interest Coverage | 11.53 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.85 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.5 | |||||
| 3-Year EBITDA Growth Rate | 11.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.3 | |||||
| 3-Year FCF Growth Rate | -9.1 | |||||
| 3-Year Book Growth Rate | 14.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.15 | |||||
| 9-Day RSI | 50.99 | |||||
| 14-Day RSI | 47.58 | |||||
| 6-1 Month Momentum % | 9.51 | |||||
| 12-1 Month Momentum % | -18.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.79 | |||||
| Quick Ratio | 2.31 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 115.78 | |||||
| Days Sales Outstanding | 70 | |||||
| Days Payable | 17.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.39 | |||||
| Dividend Payout Ratio | 0.33 | |||||
| 3-Year Dividend Growth Rate | 5.6 | |||||
| Forward Dividend Yield % | 1.39 | |||||
| 5-Year Yield-on-Cost % | 3.36 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | -0.96 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.29 | |||||
| Operating Margin % | 18.71 | |||||
| Net Margin % | 10.69 | |||||
| FCF Margin % | 8.58 | |||||
| ROE % | 12.1 | |||||
| ROA % | 6.13 | |||||
| ROIC % | 9.99 | |||||
| ROC (Joel Greenblatt) % | 28.23 | |||||
| ROCE % | 13.04 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.6 | |||||
| PE Ratio without NRI | 24.14 | |||||
| Shiller PE Ratio | 34.25 | |||||
| Price-to-Owner-Earnings | 31.42 | |||||
| PEG Ratio | 1.92 | |||||
| PS Ratio | 3.05 | |||||
| PB Ratio | 3.38 | |||||
| Price-to-Tangible-Book | 4.33 | |||||
| Price-to-Free-Cash-Flow | 35.51 | |||||
| Price-to-Operating-Cash-Flow | 15.84 | |||||
| EV-to-EBIT | 15.96 | |||||
| EV-to-EBITDA | 12.38 | |||||
| EV-to-Revenue | 3 | |||||
| EV-to-FCF | 34.98 | |||||
| Price-to-Projected-FCF | 1.62 | |||||
| Price-to-DCF (Earnings Based) | 0.77 | |||||
| Price-to-DCF (FCF Based) | 1.9 | |||||
| Price-to-Median-PS-Value | 1.28 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.44 | |||||
| Price-to-Graham-Number | 2.16 | |||||
| Price-to-Net-Current-Asset-Value | 45.62 | |||||
| Earnings Yield (Greenblatt) % | 6.27 | |||||
| FCF Yield % | 2.81 | |||||
| Forward Rate of Return (Yacktman) % | 12.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eckert & Ziegler SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 246.093 | ||
| EPS (TTM) (€) | 1.26 | ||
| Beta | 1.94 | ||
| Volatility % | 36.2 | ||
| 14-Day RSI | 47.58 | ||
| 14-Day ATR (€) | 1.422485 | ||
| 20-Day SMA (€) | 35.917 | ||
| 12-1 Month Momentum % | -18.93 | ||
| 52-Week Range (€) | 28.92 - 50.05 | ||
| Shares Outstanding (Mil) | 20.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eckert & Ziegler SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eckert & Ziegler SE Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eckert & Ziegler SE Frequently Asked Questions
What is Eckert & Ziegler SE(XTER:EUZ)'s stock price today?
The current price of XTER:EUZ is €36.04. The 52 week high of XTER:EUZ is €50.05 and 52 week low is €28.92.
When is next earnings date of Eckert & Ziegler SE(XTER:EUZ)?
The next earnings date of Eckert & Ziegler SE(XTER:EUZ) is .
Does Eckert & Ziegler SE(XTER:EUZ) pay dividends? If so, how much?
The Dividend Yield %  of Eckert & Ziegler SE(XTER:EUZ) is 1.39% (As of Today), Highest Dividend Payout Ratio of Eckert & Ziegler SE(XTER:EUZ) was 0.44. The lowest was 0.26. And the median was 0.3. The  Forward Dividend Yield % of Eckert & Ziegler SE(XTER:EUZ) is 1.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers